This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US FTC sues to block GTCR-Surmodics deal

By Wesley Brown ( March 6, 2025, 23:02 GMT | Insight) -- The US Federal Trade Commission sued to block private equity firm GTCR’s acquisition of Surmodics, a medical device coating company, alleging the deal is anticompetitive. The US FTC said that the combined company would control more than 50% of the outsourced market for hydrophilic coatings, which are often used for lifesaving medical devices such as catheters and guidewires. GTCR announced a majority investment in Biocoat, a direct competitor, in November 2022.The US Federal Trade Commission sued to block private equity firm GTCR’s acquisition of Surmodics, a medical device coating company, alleging the deal is anticompetitive....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login